Publikationen, an denen er mitarbeitet María Rosario Sánchez Martínez (12)

2022

  1. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4

  2. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Chest, Vol. 161, Núm. 2, pp. 524-534

2020

  1. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)

    Internal and Emergency Medicine

  2. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

    Thrombosis Update, Vol. 1

2019

  1. Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)

    Internal and Emergency Medicine

  2. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

    Internal and Emergency Medicine

2018

  1. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

    Thrombosis Research, Vol. 164, pp. 69-74

  2. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 4, pp. 684-691

2017

  1. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

    Research and Practice in Thrombosis and Haemostasis, Vol. 1, Núm. 2, pp. 172-179

  2. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

    American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9

  3. Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis

    Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198

  4. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595